NCT05831202: An ongoing trial by Galaxy Therapeutics INC
This trial is ongoing. It must report results 1 year, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05831202 |
|---|---|
| Title | SEAL™IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 6, 2024 |
| Completion date | Sept. 10, 2026 |
| Required reporting date | Sept. 10, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |